U.S. market Closed. Opens in 1 day 6 hours 1 minute

CRDL | Cardiol Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
RevenueN/AN/A78.76KN/AN/AN/AN/A
Cost of Revenue248.35K219.91KN/A229.54K150.57K91.49K53.34K
Gross Profit-248.35K-219.91K78.76K-229.54K-150.57K-91.49K-53.34K
Operating Expenses29.79M41.34M38.74M20.69M14.13M7.49M1.60M
Selling, General & Admin15.56M22.37M27.87M9.95M10.45M5.87M1.10M
Research & Development14.22M18.96M10.87M10.52M3.53M1.53M441.26K
Other Operating Expenses0164.44K112.23K7.40K298.80KN/A-60.56K
Operating Income-29.79M-50.34M-45.47M-20.61M-13.58M-7.39M-1.59M
Other Expenses / Income1.66M10.41M7.03M-34.45K-1.94M-8.50M-71.61K
Before Tax Income-28.13M-30.93M-31.64M-20.64M-13.68M-15.89M-1.66M
Income Tax ExpensesN/A-10.24M-6.91M7.40K299.42K663.37K60.56K
Net Income-28.13M-30.93M-31.64M-20.64M-13.68M-15.89M-1.66M
Interest ExpensesN/AN/AN/AN/A621.00663.37K60.56K
Basic Shares Outstanding64.46M62.51M43.22M29.86M25.82M15.37M22.71M
Diluted Shares Outstanding64.46M62.51M43.22M29.86M25.82M15.37M22.71M
EBITDA-29.59M-41.16M-38.44M-20.46M-11.77M-7.30M-1.50M
EBITDA Margin0.00%0.00%-48,812.06%0.00%0.00%0.00%0.00%
EBIT-28.13M-41.17M-38.55M-20.63M-13.38M-14.57M-1.54M
EBIT Margin0.00%0.00%-48,949.43%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙